31 related articles for article (PubMed ID: 21924799)
1. Discovery of histone deacetylase 8 selective inhibitors.
Tang W; Luo T; Greenberg EF; Bradner JE; Schreiber SL
Bioorg Med Chem Lett; 2011 May; 21(9):2601-5. PubMed ID: 21334896
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands.
Lu Y; Sun D; Xiao D; Shao Y; Su M; Zhou Y; Li J; Zhu S; Lu W
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885822
[TBL] [Abstract][Full Text] [Related]
3. Phage-assisted, active site-directed ligand evolution of a potent and selective histone deacetylase 8 inhibitor.
Morse JS; Sheng YJ; Hampton JT; Sylvain LD; Das S; Alugubelli YR; Chen PC; Yang KS; Xu S; Fierke CA; Liu WR
Protein Sci; 2022 Dec; 31(12):e4512. PubMed ID: 36382882
[TBL] [Abstract][Full Text] [Related]
4. Recent Developments and Future Perspectives of Purine Derivatives as a Promising Scaffold in Drug Discovery.
Rana N; Grover P; Singh H
Curr Top Med Chem; 2024; 24(6):541-579. PubMed ID: 38288806
[TBL] [Abstract][Full Text] [Related]
5. Next-generation of selective histone deacetylase inhibitors.
Yang F; Zhao N; Ge D; Chen Y
RSC Adv; 2019 Jun; 9(34):19571-19583. PubMed ID: 35519364
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of diazine-based panobinostat analogues for HDAC8 inhibition.
Balasubramaniam S; Vijayan S; Goldman LV; May XA; Dodson K; Adhikari S; Rivas F; Watkins DL; Stoddard SV
Beilstein J Org Chem; 2020; 16():628-637. PubMed ID: 32318119
[TBL] [Abstract][Full Text] [Related]
7. Inside HDAC with HDAC inhibitors.
Bertrand P
Eur J Med Chem; 2010 Jun; 45(6):2095-116. PubMed ID: 20223566
[TBL] [Abstract][Full Text] [Related]
8. Strategies in developing promising histone deacetylase inhibitors.
Zhang L; Fang H; Xu W
Med Res Rev; 2010 Jul; 30(4):585-602. PubMed ID: 19634125
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors.
Zhang Y; Feng J; Liu C; Zhang L; Jiao J; Fang H; Su L; Zhang X; Zhang J; Li M; Wang B; Xu W
Bioorg Med Chem; 2010 Mar; 18(5):1761-72. PubMed ID: 20171895
[TBL] [Abstract][Full Text] [Related]
10. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.
Liao V; Liu T; Codd R
Bioorg Med Chem Lett; 2012 Oct; 22(19):6200-4. PubMed ID: 22932316
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N-hydroxycinnamides capped with a naturally occurring moiety as inhibitors of histone deacetylase.
Huang WJ; Chen CC; Chao SW; Lee SS; Hsu FL; Lu YL; Hung MF; Chang CI
ChemMedChem; 2010 Apr; 5(4):598-607. PubMed ID: 20209563
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors.
Huang WJ; Chen CC; Chao SW; Yu CC; Yang CY; Guh JH; Lin YC; Kuo CI; Yang P; Chang CI
Eur J Med Chem; 2011 Sep; 46(9):4042-9. PubMed ID: 21712146
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors.
Lu A; Luo H; Shi M; Wu G; Yuan Y; Liu J; Tang F
Bioorg Med Chem Lett; 2011 Aug; 21(16):4924-7. PubMed ID: 21741834
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and primary activity assay of tripeptidomimetics as histone deacetylase inhibitors with linear linker and branched cap group.
Zhang Y; Feng J; Jia Y; Xu Y; Liu C; Fang H; Xu W
Eur J Med Chem; 2011 Nov; 46(11):5387-97. PubMed ID: 21924799
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
